Evaluation of Safety and Efficacy of Inhaling Colistin in Patients with VAP: A Comprehensive Systematic Review
- سال انتشار: 1398
- محل انتشار: دومین کنگره اروپایی آسیایی فارماکواپیدمیولوژی
- کد COI اختصاصی: AECPMED02_026
- زبان مقاله: انگلیسی
- تعداد مشاهده: 512
نویسندگان
Clinical Pharmacy Department, Shahid Beheshti University of Medical Sciences, Tehran, Iran
Clinical Pharmacy Department, Shahid Beheshti University ofMedical Sciences, Tehran, Iran
Chronic Respiratory Diseases Research Center (CRDRC), National Research Institute of Tuberculosis and Lung Disease (NRITLD),Shahid Beheshti University of Medical Sciences, Tehran, Iran
Clinical Pharmacy Department, Shahid Beheshti University of Medical Sciences, Tehran, Iran
چکیده
Introduction: The Incidence of VAP caused by Multidrug-resistant (MDR) gram-negative bacteria (GNB)—particularly Acinetobacter baumannii, Pseudomonas aeruginosa, and Klebsiella pneumonia—is increasing. Colistin (colistimethate sodium) is an essential polymyxin, which has favorableactivity against MDR-GNB., The polycationic/hydrophilic structure of intravenous Colistin when administered through the intravenous route, limits its penetration in lung parenchyma and resulting in systemic toxicity. Therefore, conducting a systematic review to investigate published evidence regarding the safety and efficacy of inhaling Colistin has a clinical significance. Methods: PubMed, Scopus, Cochrane, and Embase databases were searched with MESH words of Ventilator-associated pneumonia or VAP , and Colistin or colistimethate sodium or CMS , and inhaled or aerosolized or nebulized to identify and screen potentially eligible articles for inclusion in the review. Results and Discussion: Out of the initially identified articles, three studies (351 patients with ventilator-associated pneumonia) were included: 3 randomized controlled trials (RCT) examined patients with VAP. In all reviews, Pseudomonas aeruginosa and Acinetobacter baumannii were MDR pathogens which causedinfection. The mean daily dose of inhaled Colistin ranged between 8.8 to 12 MIU. The mean duration of Colistin treatment varied from 5 to 14 days. Inhaled Colistin was as effective as intravenous Colistin in the therapy of MDR bacilli VAP. Improvement of oxygenation and faster bacterial eradication time were shown in all included studies. Besides, systemic antibiotic therapy was different among studies, so it was difficultto evaluate the effect of the co-administered antibiotics on the outcomes. Conclusion: More research on this topic needs to be undertaken due to better clinical and microbiological outcomes of patients receiving inhaled Colistin.کلیدواژه ها
Ventilator-associated pneumonia, VAP, Colistin, Aerosolized,مقالات مرتبط جدید
- بررسی رابطه میزان قدرت ارتباطی با جوانی جمعیت (مطالعه موردی: دانشجویان رشته روانشناسی دانشگاه آزاد اسلامی واحد دامغان)
- رسیدگی به سقط درمانی و بازنگری قضایی آن
- درمان ناباروری با روش IVF
- اثر حفاظتی و بهبود دهندگی برخی گیاهان دارویی به عنوان آنتی اکسیدان های طبیعی بر کیفیت اسپرم های منجمد - یخ گشایی شده
- مروری بر بررسی اثر بخشی روش های کمک باروری با محوریت القاء تخمک گذاری در درمان زنان ناباور
اطلاعات بیشتر در مورد COI
COI مخفف عبارت CIVILICA Object Identifier به معنی شناسه سیویلیکا برای اسناد است. COI کدی است که مطابق محل انتشار، به مقالات کنفرانسها و ژورنالهای داخل کشور به هنگام نمایه سازی بر روی پایگاه استنادی سیویلیکا اختصاص می یابد.
کد COI به مفهوم کد ملی اسناد نمایه شده در سیویلیکا است و کدی یکتا و ثابت است و به همین دلیل همواره قابلیت استناد و پیگیری دارد.